Anatara Lifesciences Ltd

ASX (AUD): Anatara Lifesciences Ltd (ANR)

Last Price

0.006

Today's Change

+0.001 (16.66%)

Day's Change

0.006 - 0.011

Trading Volume

33,535,737

Overview

Market Cap

1 Million

Shares Outstanding

213 Million

Avg Volume

1,627,501

Avg Price (50 Days)

0.03

Avg Price (200 Days)

0.05

PE Ratio

-0.60

EPS

-0.01

Earnings Announcement

28-Jul-2025

Previous Close

0.01

Open

0.01

Day's Range

0.006 - 0.011

Year Range

0.006 - 0.073

Trading Volume

33,535,736

Price Change Highlight

1 Day Change

0.00%

5 Day Change

0.00%

1 Month Change

-14.29%

3 Month Change

-89.66%

6 Month Change

-88.89%

Ytd Change

-88.00%

1 Year Change

-85.71%

3 Year Change

-92.83%

5 Year Change

-95.74%

10 Year Change

-99.03%

Max Change

-98.43%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Anatara Lifesciences Limited engages in the research, development, and commercializing of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease; and 3FDC for the treatment of anxiety, stress, or depression. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry water. Anatara Lifesciences Limited was incorporated in 2010 and is based in Carlton, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment